Who
Melinda Lackey
General Counsel & SVP of Legal
Company insider
Files Form 4 as: General Counsel & SVP of Legal, Valion Bio; Legal & Administration, Alaunos Therapeutics.
In numbers
- Trades disclosed
- 7
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 10 Dec 2021
- Last trade
- 1 May 2026
- Last filed
- 4 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 May 2026filed 4 May 2026 | VBIO Valion Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 1 May 2026filed 4 May 2026 | VBIO Valion Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 29 Mar 2025filed 1 Apr 2025 | TCRT Alaunos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,000 at $0.00 | filing |
| 14 Aug 2024filed 16 Aug 2024 | TCRT Alaunos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,500 at $0.00 | filing |
| 15 Mar 2023filed 17 Mar 2023 | TCRT Alaunos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 15 Sep 2022filed 19 Sep 2022 | TCRT Alaunos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —185,000 at $0.00 | filing |
| 10 Dec 2021filed 13 Dec 2021 | TCRT Alaunos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —370,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.